“…Since infections with R. equi have been successfully treated with antimicrobial agents with a low level of uptake by macrophages, such as vancomycin, imipenem, and aminoglycosides (157,243,613), and relapses have occurred in patients who have received therapy with antimicrobial agents with a high level of uptake by macrophages, such as rifampin, erythromycin, doxycycline, and trimethoprim-sulfamethoxazole (157,243,420), Nordmann (420). In addition, these researchers suggested that the frequent requirement for longterm therapy in the treatment of R equi infections makes the development of a more effective oral antimicrobial agent(s) imperative (420).…”